谷歌浏览器插件
订阅小程序
在清言上使用

Panitumumab (PAN) vs bevacizumab (BEV) in metastatic colorectal cancer (mCRC) by microsatellite stable (MSS), RAS/BRAF, and HER2 amplification (HER2amp) status: Phase III PARADIGM biomarker study

T. Kato,K. Muro, J. Watanabe,K. Shitara, K. Yamazaki,H. Ohori,M. Shiozawa,H. Yasui,E. Oki, T. Sato,T. Naitoh, Y. Komatsu,J. Soeda, K. Yamamoto,R. Yamashita,K. Akagi,A. Ochiai,H. Uetake,K. Tsuchihara, T. Yoshino

ANNALS OF ONCOLOGY(2023)

引用 0|浏览10
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要